Jamie Heywood
Founder and CEO, Alden Scientific
Jamie Heywood is listed as Founder and CEO, Alden Scientific. Jamie is scheduled to speak at ICHOM Conference 2026 on 8 December 2026.
Compiled from published conference agendas; not yet confirmed by Jamie. Is this you? Claim this profile.
About
Jamie Heywood is a MIT-trained mechanical engineer who entered biomedicine after his brother was diagnosed with ALS in 1999. Prior to founding Alden Scientific, a digital biology company that develops advanced individual predictions to manage health, disease, and aging, Jamie founded the ALS Therapy Development Institute, PatientsLikeMe, and AOBiome, and co-founded Genetic Networks, The SocialMedwork, and iCarbonX International. His focus has been on addressing fundamental improvements in the discovery and development of treatments and management of health and disease and in empowering individuals. Jamie’s work has been profiled in The New Yorker, 60 Minutes, TEDMED, Pulitzer Prize winner Jonathan Wiener’s book, His Brother’s Keeper, and the Sundance award-winning documentary So Much So Fast.
Upcoming
ICHOM Conference 2026 7 December 2026 – 9 December 2026
- Redesigning Healthcare: What AI Can Inspire and Enable Us to Achieve Speaker · 8 December 2026
Spoke alongside
People who have shared a session with Jamie at events on B2DB.
- Emilia Javorsky MD, MPH Director of the Futures Program · Future of Life Institute 1 shared session
- Rafid Fadul, MD Chief Medical Officer · ARPA-H 1 shared session
- Tim Kelsey Managing Director · Hunter Healthcare 1 shared session